Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 16
2004 16
2005 9
2006 9
2007 9
2008 11
2009 19
2010 13
2011 10
2012 13
2013 10
2014 15
2015 18
2016 10
2017 14
2018 14
2019 8
2020 15
2021 19
2022 12
2023 17
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gundem G, Levine MF, Roberts SS, Cheung IY, Medina-Martínez JS, Feng Y, Arango-Ossa JE, Chadoutaud L, Rita M, Asimomitis G, Zhou J, You D, Bouvier N, Spitzer B, Solit DB, Dela Cruz F, LaQuaglia MP, Kushner BH, Modak S, Shukla N, Iacobuzio-Donahue CA, Kung AL, Cheung NV, Papaemmanuil E. Gundem G, et al. Nat Genet. 2023 Jun;55(6):1022-1033. doi: 10.1038/s41588-023-01395-x. Epub 2023 May 11. Nat Genet. 2023. PMID: 37169874
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells.
Li S, Liu M, Do MH, Chou C, Stamatiades EG, Nixon BG, Shi W, Zhang X, Li P, Gao S, Capistrano KJ, Xu H, Cheung NV, Li MO. Li S, et al. Nature. 2020 Nov;587(7832):121-125. doi: 10.1038/s41586-020-2850-3. Epub 2020 Oct 21. Nature. 2020. PMID: 33087933 Free PMC article.
Pretargeting: A Path Forward for Radioimmunotherapy.
Cheal SM, Chung SK, Vaughn BA, Cheung NV, Larson SM. Cheal SM, et al. J Nucl Med. 2022 Sep;63(9):1302-1315. doi: 10.2967/jnumed.121.262186. J Nucl Med. 2022. PMID: 36215514 Free article. Review.
Bispecific antibodies for the treatment of neuroblastoma.
Espinosa-Cotton M, Cheung NV. Espinosa-Cotton M, et al. Pharmacol Ther. 2022 Sep;237:108241. doi: 10.1016/j.pharmthera.2022.108241. Epub 2022 Jul 10. Pharmacol Ther. 2022. PMID: 35830901 Free PMC article. Review.
Radioimmunotherapy of human tumours.
Larson SM, Carrasquillo JA, Cheung NK, Press OW. Larson SM, et al. Nat Rev Cancer. 2015 Jun;15(6):347-60. doi: 10.1038/nrc3925. Nat Rev Cancer. 2015. PMID: 25998714 Free PMC article. Review.
GD2-targeted immunotherapy and radioimmunotherapy.
Dobrenkov K, Cheung NK. Dobrenkov K, et al. Semin Oncol. 2014 Oct;41(5):589-612. doi: 10.1053/j.seminoncol.2014.07.003. Epub 2014 Jul 21. Semin Oncol. 2014. PMID: 25440605 Free PMC article. Review.
Chronic neuroblastoma.
Kushner BH, Kramer K, Cheung NK. Kushner BH, et al. Cancer. 2002 Sep 15;95(6):1366-75. doi: 10.1002/cncr.10800. Cancer. 2002. PMID: 12216106 Free article.
Immunotherapy of Childhood Sarcomas.
Roberts SS, Chou AJ, Cheung NK. Roberts SS, et al. Front Oncol. 2015 Aug 7;5:181. doi: 10.3389/fonc.2015.00181. eCollection 2015. Front Oncol. 2015. PMID: 26301204 Free PMC article. Review.
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
Kramer K, Pandit-Taskar N, Kushner BH, Zanzonico P, Humm JL, Tomlinson U, Donzelli M, Wolden SL, Haque S, Dunkel I, Souweidane MM, Greenfield JP, Tickoo S, Lewis JS, Lyashchenko SK, Carrasquillo JA, Chu B, Horan C, Larson SM, Cheung NV, Modak S. Kramer K, et al. J Hematol Oncol. 2022 Nov 12;15(1):165. doi: 10.1186/s13045-022-01383-4. J Hematol Oncol. 2022. PMID: 36371226 Free PMC article. Clinical Trial.
265 results